GRALNasdaqServices-Medical LaboratoriesFiscal year ends December 31
GRAIL, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$122.42+4.61 (+3.91%)
Close on Oct 19, 2026
- Market cap
- $5.28B
- P/E (TTM)
- –
- Dividend yield
- –
Grail statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Services-Medical Laboratories companies for comparison
Valuation
| Measure | Grail | Industry median |
|---|---|---|
| Market Cap | $5.47B | $1.11B |
| Enterprise Value | $4.61B | $1.41B |
| PS Ratio | 33.09 | 1.60 |
| PB Ratio | 2.15 | 3.03 |
| P/TBV Ratio | 7.18 | 4.99 |
Enterprise value
| Measure | Grail | Industry median |
|---|---|---|
| EV / Sales | 27.89 | 1.69 |
Income (trailing twelve months)
| Measure | Grail | Industry median |
|---|---|---|
| Revenue | $165.26M | $561.90M |
| Operating Income | -$559.25M | -$1.81M |
| Pretax Income | -$529.47M | -$572.42K |
| Net Income | -$391.59M | -$1.16M |
| EBITDA | -$559.25M | -$20.72K |
| EPS (Diluted) | -$9.74 | -$0.02 |
Margins
| Measure | Grail | Industry median |
|---|---|---|
| Operating Margin | -338.4% | -4.45% |
| Pretax Margin | -320.4% | 1.54% |
| Profit Margin | -236.9% | -2.91% |
| EBITDA Margin | -338.4% | 2.41% |
| FCF Margin | -179.2% | 3.13% |
Returns
| Measure | Grail | Industry median |
|---|---|---|
| Return on Equity (ROE) | -16.1% | 1.84% |
| Return on Assets (ROA) | -14.1% | -3.06% |
| Return on Invested Capital (ROIC) | -26.0% | 2.11% |
| Return on Capital Employed (ROCE) | -20.3% | -0.57% |
Growth
| Measure | Grail | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 23.1% | 6.92% |
| Revenue Growth (3Y CAGR) | 38.4% | 10.9% |
Balance sheet
| Measure | Grail | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $859.54M | $48.71M |
| Net Cash (Debt) | $859.54M | $205.49K |
| Net Cash Per Share | $19.24 | $0.01 |
| Equity (Book Value) | $2.54B | $235.16M |
| Book Value Per Share | $56.93 | $3.48 |
| Tangible Book Value | $761.27M | $703.69K |
| Working Capital | $831.18M | $30.48M |
Financial position
| Measure | Grail | Industry median |
|---|---|---|
| Current Ratio | 10.95 | 1.40 |
| Quick Ratio | 10.53 | 1.02 |
Cash flow (trailing twelve months)
| Measure | Grail | Industry median |
|---|---|---|
| Operating Cash Flow | -$294.75M | $3.10M |
| Capital Expenditures | -$1.41M | -$18.62M |
| Free Cash Flow | -$296.16M | $23.73M |
| FCF Per Share | -$6.63 | $0.37 |
Efficiency
| Measure | Grail | Industry median |
|---|---|---|
| Asset Turnover | 0.06 | 0.87 |
| Revenue Per Employee | $181.61K | $228.48K |
| Profits Per Employee | -$430.32K | -$5.75K |
| Employee Count | 910 | 910 |
Dividends and yields
| Measure | Grail | Industry median |
|---|---|---|
| Earnings Yield | -7.16% | -0.59% |
| FCF Yield | -5.42% | 1.74% |
Shares
| Measure | Grail | Industry median |
|---|---|---|
| Shares Outstanding | 44,666,200 | 58,282,400 |
| Shares Change (YoY) | 18.5% | 2.68% |
| Shares Change (QoQ) | 8.59% | 0.32% |
| Float | 39,675,800 | 33,780,100 |
| Shares Held by Insiders | 11.2% | 16.4% |
| Shares Held by Institutions | 87.6% | 85.9% |
Taxes
| Measure | Grail | Industry median |
|---|---|---|
| Income Tax | -$137.88M | $697.00K |
Scores
| Measure | Grail | Industry median |
|---|---|---|
| Altman Z-Score | 5.53 | 2.05 |
| Piotroski F-Score | 5 | 5 |
Calculated by StockData from Grail's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.